Orbimed Advisors LLC: insider buys
Every open-market stock purchase reported by Orbimed Advisors LLC to the SEC on Form 4.
Total bought$20M
Purchases2
Companies2
Last purchase filedJul 29, 2026
Return on these buys-18%
Orbimed Advisors LLC has made 2 open-market purchases worth $20M in 2 companies since Oct 10, 2025, according to SEC Form 4 filings. The most recent was filed on Jul 29, 2026: 1,000,000 shares of SCTX at $15.00 (Director), worth $15M. Taken together, these purchases are down 18% at the latest closing prices (split-adjusted, weighted by amount).
Companies Orbimed Advisors LLC bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| SCTX | Scribe Therapeutics, Inc. | Director | 1 | $15M | +2.8% | Jul 29 |
| ACET | Adicet Bio, Inc. | 10% Owner | 1 | $5M | -79% | Oct 10 |
Get the next Orbimed Advisors LLC purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Jul 29 | SCTXScribe Therapeutics, Inc. | Orbimed Advisors LLC +1Director | $15M | 1,000,000 | $15.00 | +2.8% | +287% | Jul 27 | SEC |
| Oct 10 | ACETAdicet Bio, Inc. | Orbimed Advisors LLC +710% Owner | $5M | 5,000,000 | $1.00 | -79% | — | Oct 8 | SEC |